文献速递糖尿病肥胖与代谢综合征

MTNR1B基因型与碳水化合物数量和膳食血糖指数对口服葡萄糖负荷后血糖反应的影响:OmniCarb试验

MTNR1B genotype and effects of carbohydrate quantity and dietary glycaemic index on glycaemic response to an oral glucose load: the OmniCarb trial.
PubMed 文献 · Diabetologia · 2023-12-05

本研究纳入150名参与者,进行为期5周的随机交叉对照喂养试验,评估四种高/低血糖指数和高/低碳水化合物含量饮食。结果显示,携带MTNR1B-rs10830963风险G等位基因者在高碳水/高GI饮食后2小时OGTT血糖AUC最大(β 134.32 [SE 45.69] mmol/l × min;p=0.004)。在高碳水饮食中降低GI可降低风险G等位基因携带者的OGTT后血糖。

要点

  • 携带MTNR1B-rs10830963风险G等位基因者,在高碳水/高GI饮食后2小时OGTT血糖AUC最大。
  • 风险G等位基因携带者仅在高碳水/高GI饮食后0-60分钟和0-90分钟血糖增量更大。
  • 高碳水饮食中降低GI可降低风险G等位基因携带者的60分钟OGTT血糖及0-60分钟血糖增量。

核心结论

  • 携带MTNR1B-rs10830963风险G等位基因与摄入高碳水化合物和高GI饮食后更大的血糖反应相关。
  • 在高碳水化合物饮食中降低GI可能降低风险G等位基因携带者的OGTT后血糖浓度。

研究设计与样本

  • 随机交叉对照喂养试验,纳入150名参与者,接受四种饮食(高/低GI与高/低碳水化合物含量组合)各5周。
  • 对MTNR1B-rs10830963(C/G)变异进行基因分型,在基线和每种饮食干预结束时测量2小时OGTT期间的血糖反应。

主要发现

  • 在高碳水/高GI饮食后,携带风险G等位基因(CG/GG vs CC基因型)与2小时OGTT血糖AUC最大相关(β 134.32 [SE 45.69] mmol/l × min;p=0.004)。
  • 风险G等位基因携带者在高碳水/高GI饮食干预后0-60分钟血糖增量(β 1.26 [0.47] mmol/l;p=0.008)和0-90分钟血糖增量(β 1.10 [0.50] mmol/l;p=0.028)更大,但在其他三种饮食后无此差异。
  • 在高碳水化合物含量下,降低GI水平可降低60分钟OGTT后血糖(平均-0.67 [95% CI:-1.18,-0.17] mmol/l)和0-60分钟血糖增量(平均-1.00 [95% CI:-1.67,-0.33] mmol/l)及0-90分钟血糖增量,尤其在风险G等位基因携带者中(交互作用p<0.05)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: A type 2 diabetes-risk-increasing variant, MTNR1B (melatonin receptor 1B) rs10830963, regulates the circadian function and may influence the variability in metabolic responses to dietary carbohydrates. We investigated whether the effects of carbohydrate quantity and dietary glycaemic index (GI) on glycaemic response during OGTTs varied by the risk G allele of MTNR1B-rs10830963. METHODS: This study included participants (n=150) of a randomised crossover-controlled feeding trial of four diets with high/low GI levels and high/low carbohydrate content for 5 weeks. The MTNR1B-rs10830963 (C/G) variant was genotyped. Glucose response during 2 h OGTT was measured at baseline and the end of each diet intervention. RESULTS: Among the four study diets, carrying the risk G allele (CG/GG vs CC genotype) of MTNR1B-rs10830963 was associated with the largest AUC of glucose during 2 h OGTT after consuming a high-carbohydrate/high-GI diet (β 134.32 [SE 45.69] mmol/l × min; p=0.004). The risk G-allele carriers showed greater increment of glucose during 0-60 min (β 1.26 [0.47] mmol/l; p=0.008) or 0-90 min (β 1.10 [0.50] mmol/l; p=0.028) after the high-carbohydrate/high-GI diet intervention, but not after consuming the other three diets. At high carbohydrate content, reducing GI levels decreased 60 min post-OGTT glucose (mean -0.67 [95% CI: -1.18, -0.17] mmol/l) and the increment of glucose during 0-60 min (mean -1.00 [95% CI: -1.67, -0.33] mmol/l) and 0-90 min, particularly in the risk G-allele carriers (pinteraction <0.05 for all). CONCLUSIONS/INTERPRETATION: Our study shows that carrying the risk G allele of MTNR1B-rs10830963 is associated with greater glycaemic responses after consuming a diet with high carbohydrates and high GI levels. Reducing GI in a high-carbohydrate diet may decrease post-OGTT glucose concentrations among the risk G-allele carriers.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Heianza Y, Zhou T, Wang X, et al. MTNR1B genotype and effects of carbohydrate quantity and dietary glycaemic index on glycaemic response to an oral glucose load: the OmniCarb trial. Diabetologia. 2023. PMID: 38052941. doi:10.1007/s00125-023-06056-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。